Table 1.
Potential metabolic biomarkers differentiating the NAFLD and control subjects using different analytical modes (T3-pos, T3-neg, amide-pos, amide-neg). All metabolic identifications have been confirmed by MS and MS/MS. Fold change was calculated by comparing the abundance level of the metabolite in the NAFLD group vs. the control group (NAFLD/Control). P value was calculated using the Student’s t-test.
Mode | Metabolite | Formula | Mass (Da) | Retention time (min) | Adductsa | Observed (m/z) | Mass error (ppm) | Fold change | P value |
---|---|---|---|---|---|---|---|---|---|
T3-pos | Valerylcarnitine | C12H23NO4 | 245.1627 | 3.31 | [M + H]+ | 246.1694 | −2.25 | 1.92 | 0.0386 |
Octanoylcarnitine | C15H29NO4 | 287.2097 | 4.47 | [M + H]+ | 288.2164 | −1.74 | 4.65 | 0.0124 | |
Hydroxyundecanoyl carnitine | C18H35NO5 | 345.2515 | 5.08 | [M + H-H2O]+ | 328.2480 | −0.59 | 2.01 | 0.0197 | |
Hydroxydodecanedioic acid | C12H22O5 | 246.1461 | 4.50 | [M + H-H2O]+ | 229.1428 | −2.39 | 2.11 | 0.0045 | |
PE(17:0/0:0) | C22H46NO7P | 467.3018 | 7.40 | [M + H]+ | 468.3091 | 1.26 | 1.76 | 0.0121 | |
LPC(18:3) | C26H48NO7P | 517.3168 | 7.81 | [M + H]+ | 518.3242 | 0.22 | 1.55 | 0.0123 | |
LPC(20:3) | C28H52NO7P | 545.3481 | 8.91 | [M + H]+ | 546.3561 | 1.27 | 1.64 | 0.0300 | |
25-Hydroxyvitamin D3-26,23-lactol | C27H42O4 | 430.3083 | 9.38 | [M + H]+ | 431.3155 | −0.20 | 1.60 | 0.0203 | |
MG(18:1) | C21H40O4 | 356.2925 | 13.77 | [M + H]+ | 357.3016 | −0.53 | 3.65 | 0.0250 | |
T3-neg | Deoxycholic acid 3-glucuronide | C30H48O10 | 568.3247 | 5.83 | [M−H]- | 567.3165 | −1.70 | 4.76 | 0.0084 |
Tuftsin | C21H40N8O6 | 500.3071 | 5.34 | [M−H]- | 499.3007 | 1.75 | 3.89 | 0.0211 | |
LPC(20:3) | C28H52NO7P | 545.3481 | 8.91 | [M + FA-H]- | 590.3411 | −9.61 | 1.77 | 0.0210 | |
Retinyl beta-glucuronide | C26H38O7 | 462.2618 | 5.45 | [M−H]- | 461.2554 | 1.93 | 0.64 | 0.0427 | |
Amide-pos | LPC(14:0) | C22H46NO7P | 467.3012 | 3.39 | [M + H]+ | 468.3097 | 2.65 | 2.73 | 0.0026 |
DG(20:3/20:4) | C43H70O5 | 666.5234 | 2.43 | [M + H]+ | 684.5542 | 1.62 | 7.22 | 0.0261 | |
Valerylcarnitine | C12H23NO4 | 245.1627 | 7.36 | [M + H]+ | 246.1697 | −0.99 | 1.99 | 0.0045 | |
3-Hydroxy-cis-5-tetradecenoylcarnitine | C21H39NO5 | 385.2828 | 3.34 | [M + H-H2O]+ | 368.2798 | 0.58 | 1.69 | 0.0057 | |
LPC(20:3) | C28H52NO7P | 545.3491 | 3.31 | [M + H]+ | 546.3564 | 1.83 | 1.67 | 0.0224 | |
Hydroxylauroylcarnitine | C19H37NO5 | 359.2672 | 5.40 | [M + H-H2O]+ | 342.2641 | 0.69 | 1.55 | 0.0251 | |
DG(18:1)/18:2) | C39H70O5 | 618.5191 | 2.45 | [M + H-H2O]+ | 636.5558 | −5.16 | 2.74 | 0.0423 | |
Amide-neg | Cortolone-3-glucuronide | C27H42O11 | 542.2727 | 7.33 | [M−H]- | 541.2697 | 7.93 | 2.58 | 0.0004 |
Tetrahydroaldosterone-3-glucuronide | C27H40O11 | 540.2571 | 7.22 | [M−H]- | 539.2548 | 9.24 | 2.02 | 0.0007 | |
LPC(18:0) | C26H54NO7P | 523.3638 | 3.34 | [M + FA-H]- | 568.3603 | −3.31 | 2.13 | 0.0323 | |
Retinyl beta-glucuronide | C26H38O7 | 462.2618 | 3.11 | [M−H]- | 461.2564 | 4.17 | 0.57 | 0.0228 |
The metabolite adducts of the highest intensity were chosen to represent the abundance of given metabolites.